PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 187 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 5.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $358,000 | +62.7% | 15,010 | +84.8% | 0.29% | +97.3% |
| Q2 2019 | $220,000 | -32.9% | 8,124 | -34.0% | 0.15% | +2.1% |
| Q3 2018 | $328,000 | -69.4% | 12,308 | -56.6% | 0.14% | -57.9% |
| Q2 2018 | $1,071,000 | +104.4% | 28,362 | +192.4% | 0.34% | +129.7% |
| Q3 2017 | $524,000 | +5.6% | 9,700 | -53.8% | 0.15% | -38.6% |
| Q2 2016 | $496,000 | -9.3% | 21,000 | -21.6% | 0.24% | -34.2% |
| Q1 2016 | $547,000 | – | 26,800 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 232,952 | $5,498,000 | 5.39% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,673,727 | $86,700,000 | 3.41% |
| Redmile Group, LLC | 1,466,537 | $34,610,000 | 3.31% |
| SECTORAL ASSET MANAGEMENT INC | 1,229,382 | $29,013,000 | 3.00% |
| HARVEY CAPITAL MANAGEMENT INC | 206,530 | $4,874,000 | 2.44% |
| Marcus Capital, LLC | 75,150 | $1,774,000 | 1.87% |
| Cormorant Asset Management, LP | 396,000 | $9,346,000 | 1.32% |
| Rail-Splitter Capital Management, LLC | 221,414 | $5,225,000 | 1.25% |
| Temasek Holdings (Private) Ltd | 6,583,568 | $155,372,000 | 1.21% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 636,526 | $15,022,000 | 0.84% |